Testing effectiveness (Phase 2)Ended earlyNCT04438382
What this trial is testing
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSteroid-Refractory Pneumonitis
ECOG-ACRIN Cancer Research Group 1